• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin.

作者信息

Abenavoli Ludovico, Milic Natasa, Capasso Francesco

出版信息

Endocrine. 2012 Dec;42(3):754-5. doi: 10.1007/s12020-012-9677-0.

DOI:10.1007/s12020-012-9677-0
PMID:22527892
Abstract
摘要

相似文献

1
Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin.非酒精性脂肪性肝病中的抗氧化治疗：水飞蓟素的作用
Endocrine. 2012 Dec;42(3):754-5. doi: 10.1007/s12020-012-9677-0.
2
Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.非酒精性脂肪性肝病与心血管风险：代谢方面和新的治疗方法。
Endocrine. 2011 Dec;40(3):332-43. doi: 10.1007/s12020-011-9530-x. Epub 2011 Sep 6.
3
Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk?非酒精性脂肪性肝病（NAFLD）会增加心血管疾病风险吗？
Endocr Metab Immune Disord Drug Targets. 2008 Dec;8(4):301-7. doi: 10.2174/187153008786848268.
4
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.非酒精性脂肪肝疾病是否会导致心血管疾病？现有知识和差距。
Atherosclerosis. 2019 Mar;282:110-120. doi: 10.1016/j.atherosclerosis.2019.01.029. Epub 2019 Jan 30.
5
The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome.非酒精性脂肪性肝病、动脉粥样硬化和代谢综合征之间的相互关联。
J Gastroenterol. 2009;44(11):1162-4. doi: 10.1007/s00535-009-0140-9.
6
Nonalcoholic fatty liver disease as a component of the metabolic syndrome.非酒精性脂肪性肝病作为代谢综合征的一个组成部分。
Curr Gastroenterol Rep. 2008 Feb;10(1):73-80. doi: 10.1007/s11894-008-0012-0.
7
[Metabolic fatty liver diseases: hepatic consequences of the metabolic syndrome].[代谢性脂肪性肝病：代谢综合征的肝脏后果]
Gastroenterol Clin Biol. 2007 Dec;31(12):1127-34. doi: 10.1016/s0399-8320(07)78350-1.
8
Clear messages from sonographic shadows? Links between metabolic disorders and liver disease, and what to do about them.超声阴影传递的明确信息？代谢紊乱与肝脏疾病之间的联系以及应对之策。
J Gastroenterol Hepatol. 2003 Oct;18(10):1115-7. doi: 10.1046/j.1440-1746.2003.03170.x.
9
Review article: the metabolic syndrome and non-alcoholic fatty liver disease.综述文章：代谢综合征与非酒精性脂肪性肝病
Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:31-6. doi: 10.1111/j.1365-2036.2005.02592.x.
10
Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.2012 年多萝西·霍奇金讲座：非酒精性脂肪性肝病、胰岛素抵抗和异位脂肪：糖尿病管理中的新问题。
Diabet Med. 2012 Sep;29(9):1098-107. doi: 10.1111/j.1464-5491.2012.03732.x.

引用本文的文献

1
Effects of Milk Thistle Extract Supplementation on Performance, Egg Quality, and Liver Pathology of Laying Hens' Fed Diets Lacking Supplemental Choline Chloride.水飞蓟提取物对缺乏氯化胆碱日粮蛋鸡生产性能、蛋品质及肝脏病理的影响
Vet Sci. 2025 Jan 21;12(2):77. doi: 10.3390/vetsci12020077.
2
Therapeutic Effects of Milk Thistle ( L.) and Artichoke ( L.) on Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Rats.奶蓟（L.）和朝鲜蓟（L.）对 2 型糖尿病大鼠非酒精性脂肪肝的治疗作用。
Can J Gastroenterol Hepatol. 2022 Feb 11;2022:2868904. doi: 10.1155/2022/2868904. eCollection 2022.
3
Antioxidant Effects and Phytochemical Properties of Seven Taiwanese Species Extracts.

本文引用的文献

1
Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.非酒精性脂肪性肝病与心血管风险：代谢方面和新的治疗方法。
Endocrine. 2011 Dec;40(3):332-43. doi: 10.1007/s12020-011-9530-x. Epub 2011 Sep 6.
2
Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.非酒精性脂肪性肝病伴丙氨酸氨基转移酶升高与年轻汉族男性的胰岛素抵抗有关。
Endocrine. 2012 Feb;41(1):70-5. doi: 10.1007/s12020-011-9511-0. Epub 2011 Jul 28.
3
Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice.
七种台湾特有种植物萃取物之抗氧化与植化性质探讨。
Molecules. 2021 Jun 28;26(13):3935. doi: 10.3390/molecules26133935.
4
Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.壳聚糖功能化的脂质-聚合物杂化纳米粒用于水飞蓟宾的口服递送和增强 NAFLD 的降脂作用。
J Nanobiotechnology. 2018 Sep 4;16(1):64. doi: 10.1186/s12951-018-0391-9.
5
Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study.载脂蛋白相关磷脂酶 A2 与非酒精性脂肪性肝病患病率的相关性：APAC 研究结果。
Sci Rep. 2018 Jul 4;8(1):10127. doi: 10.1038/s41598-018-28494-8.
6
Comparison of the Hepatoprotective Effects of Four Endemic Cirsium Species Extracts from Taiwan on CCl₄-Induced Acute Liver Damage in C57BL/6 Mice.比较台湾四种蓟属植物提取物对 C57BL/6 小鼠四氯化碳诱导急性肝损伤的保护作用。
Int J Mol Sci. 2018 Apr 30;19(5):1329. doi: 10.3390/ijms19051329.
7
Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma.从奶蓟种子中鉴定出水飞蓟宾 A 是过氧化物酶体增殖物激活受体 γ 的激动剂。
J Nat Prod. 2014 Apr 25;77(4):842-7. doi: 10.1021/np400943b. Epub 2014 Mar 5.
8
Non-alcoholic fatty liver disease: a diabetologist's perspective.非酒精性脂肪性肝病：糖尿病学家的视角。
Endocrine. 2014 Apr;45(3):344-53. doi: 10.1007/s12020-013-0087-8. Epub 2013 Nov 28.
水飞蓟宾对肥胖糖尿病小鼠内皮功能障碍及 ADMA 水平的影响。
Cardiovasc Diabetol. 2011 Jul 14;10:62. doi: 10.1186/1475-2840-10-62.
4
Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease.水飞蓟素在治疗非酒精性脂肪性肝病纤维化发展中的作用。
Hepatol Res. 2011 Jul;41(7):668. doi: 10.1111/j.1872-034X.2011.00823.x. Epub 2011 Jun 22.
5
Role of adipocytokines in predicting the development of diabetes and its late complications.脂肪细胞因子在预测糖尿病及其晚期并发症的发展中的作用。
Endocrine. 2009 Dec;36(3):397-403. doi: 10.1007/s12020-009-9234-7. Epub 2009 Sep 25.